I'm interested in conversations about and I want to talk about
Know exactly what you want?
Show search

Notification

Error

<123

The "mothership" and pca spread.

User
Posted 20 Sep 2023 at 22:09

Originally Posted by: Online Community Member
even a prostate that has been treated with RT can still act as a "mothership" to send out chemical messages to micromets in the blood stream or hiding elsewhere in the body for years.

Can I get some clarification on this idea please? Is this suggesting that there can still be some cancer left after RT or that even if there's no cancer present in the prostate it can still act as a "mothership"?

I asked this question first up and Dave repeated it later in the thread. I get the impression from later posts that this is not the case, so the "mothership" isn't always a "mothership" and indeed any met. might equally be classified as a "mothership", though if it comes down to the more basic ability of cancer to spread mets, then you could say that cancerous lymph glands [for example] are a bigger threat to spread than the prostate.

Personally, I don't like the term "mothership" and I don't know who came up with it but it's a loaded term that could lead people into believing the prostate is an irrespressible monster. The clear beneficiaries of that thinking are urologists who back surgery.

 

Jules

Edited by member 20 Sep 2023 at 23:57  | Reason: Not specified

User
Posted 20 Sep 2023 at 22:54

Hi Andy62

Am I missing something here? Are you talking about 'mothership' theory or STAMPEDE therapy? Are they not two different things. One is about cancer tumours communicating with remote cells whereas STAMPEDE study was simply to find the drugs that can 'cure' cancer that has spread? STAMPEDE study has a strong scientific basis whereas 'mothership' concept is simply an unverified hypothesis.

 'Physics is like sex: sure, it may give some practical results, but that’s not why we do it.'                    Richard Feynman (1918-1988) Nobel Prize laureate

 

 

User
Posted 21 Sep 2023 at 00:25

You are right that STAMPEDE was mainly looking at repurposing existing drugs, but in STAMPEDE Arm H, they repurposed radiotherapy.

There had been a previous relatively small trial HORRAD which had tried prostate radiotherapy on metastatic patients. It didn't find any benefits, but there was a suspicion that for those with very few mets, there might be a survival benefit, although the numbers involved in that trial were too small to be statistically significant.

STAMPEDE Arm H was established to look at this again, and was a much bigger trial. It confirmed the previous suspicion that those with a low tumour burden (fewer than 5 bone mets), treating the prostate with radiotherapy did improve overall survival benefit, and progression free survival during the observation period.

Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial

The trial was run from 2013 to 2016 and reported in 2018. It would be good if they could report again having had longer since then to monitor the patients.

The results were regarded as significant, and this became the standard of care in the UK around 2019.

User
Posted 21 Sep 2023 at 14:20

In the context of men trying to make a decision about their treatment now, in particularly RT versus RP, the 'mothership' hypothesis is a red herring  because it suggests that a bunch of cancer cells (mothership)can 'communicate' with another cancer cell/s remote from the 'mothership' to 'instruct' it/them to multiply. As far as I know from my research this is a concept which has no scientific validity; if I am wrong I would love to hear from anyone reading this.

 'Physics is like sex: sure, it may give some practical results, but that’s not why we do it.'                    Richard Feynman (1918-1988) Nobel Prize laureate

 

 

User
Posted 21 Sep 2023 at 14:39

Mothership is irrelevant for curative treatments (at least RT and RP) because they both zap it, so not a consideration for anyone offered such a choice of treatments.

It only comes into play for people with mets, and then yes, STAMPEDE showed there was an effect on delaying progression when fewer than 5 bone mets, and as a result those diagnosed metastatic with fewer than 5 bone mets are now offered RT on the prostate as standard of care.

User
Posted 21 Sep 2023 at 17:04

Pratap

The ability of cancer cells to 'communicate' around the body using chemotactic guidance factors is something that has been well researched (although probably not PCa specific). This gives some credence to the 'mothership' theory although only in the most basic of terms - any metastasis could act in the same way at some point.

There is an interesting article that talks about chemotaxis in cancer cells and how they 'communicate' at this link  Chemotaxis in cancer cell.

 

Edited by member 21 Sep 2023 at 17:05  | Reason: linking

User
Posted 21 Sep 2023 at 18:14

To Pratap 

As previously stated (and I have no idea why the moderators remove thr names of the Drs when these names are readily accessed on the internet ) there have been papers written on the subject and there is now an ongoing trial .Its up to each individual to make  their own choice of treatment but new ways of treating cancer  are always being investigated .It may be unfortunate for some men that have gone down the RT route to eventually dscover that their choice may not be the one that offers the best outcome .But as recently as 5 years ago the treatments for prostate cancer were not in the same league as the new treatments coming online  today. I know from personal experience that I was very happy to be rid of my cancerous prostate (I was classed as high risk after the prostectomy altered my Gleason score to 4 ,3  5 ) and so far 7 years on from diagnosis and three years on from removal I am still here to shout about it with an undetectable PSA and very few side effects from the treatment .

User
Posted 22 Sep 2023 at 09:24

Originally Posted by: Online Community Member
I have no idea why the moderators remove thr names of the Drs

Clinician's names not allowed in this forum. Link to their relevant research papers.

User
Posted 02 Oct 2023 at 18:36

Ok I know somebody who had his prostrate removed and was fine for 11 years but just recently I spoke to him and cancer has come  back and spread all over his body...

Cheers Tonyc01 

User
Posted 02 Oct 2023 at 22:14

That is very unfortunate for him. Do you know if he was having regular follow up PSA tests? I suspect that, as it is now all over his body, it probably recurred within the first year or two but nobody was watching. 

The story does lend weight to the argument, removing the mothership does not prevent metastasis.

Dave

User
Posted 03 Oct 2023 at 11:09

It is difficult to remove all the prostate cells in a prostatectomy. There will probably be some left in the case nerve sparing, hopefully not cancerous, and at the apex (bottom) of the prostate, it diffuses into the surrounding tissues and aggressive removal here (which is necessary if the cancer is in the apex) reduces the chances of being continent afterwards.

This means you are likely to be left with some prostate cells after a prostatectomy, but hopefully not cancerous ones.

In cases where you are in remission for 10+ years and it then recurs, I do wonder if that's a new cancer forming in some remaining cells. After all, prostate cancer is usually a multi-focal cancer (springing up in several places, and not just one.

As mentioned, if someone is suddenly discovered to be heavily metastatic 10+ years after a prostatectomy, that might be lack of monitoring. It may be that the cancer was a non-secreter (doesn't generate PSA), but in that case, monitoring is via scans, although I don't know how long those go on for - probably not 10 years.

Edited by member 03 Oct 2023 at 12:07  | Reason: Not specified

User
Posted 03 Oct 2023 at 13:35
The "residual cells in the apex" are what my Urologist says are the cause of my persistent PSA.

I have my fingers crossed whatever it is it will not have increased at my next test this month!

User
Posted 03 Oct 2023 at 14:28

'Ok I know somebody who had his prostrate removed and was fine for 11 years but just recently I spoke to him and cancer has come  back and spread all over his body..'

I am not sure what is your point here? I are suggesting that that an evidence of the 'mothership' theory?

 

 

 'Physics is like sex: sure, it may give some practical results, but that’s not why we do it.'                    Richard Feynman (1918-1988) Nobel Prize laureate

 

 

User
Posted 03 Oct 2023 at 14:45

Hi ok thr chap involved hsd his prostrate removed snd was fine gor 8 years,but for some un known reason it has come back an now he's having further treatment he told me it had spread to most organs in his body...but he fidnt say what caused it since his p gland had been removed...

Cheers tonyc01

User
Posted 05 Oct 2023 at 07:18

Originally Posted by: Online Community Member

Hi ok thr chap involved hsd his prostrate removed snd was fine gor 8 years,but for some un known reason it has come back an now he's having further treatment he told me it had spread to most organs in his body...but he fidnt say what caused it since his p gland had been removed...

Cheers tonyc01

This make me wonder, regardless of whether you do or don't still have a prostate, where is recurrence likely to occur after say 7-10 years?

Is it going to come from the prostate bed, the seminal vesicles, local nerves or does it perform a nightmare trick and turn up in bones or remote locations where it's going to be hard to treat? I ask because it relates to the dreaded micro-mets that have rated a few mentions in this topic.

Jules

User
Posted 05 Oct 2023 at 11:09

I don't know the answer to your question about where it's most likely to occur after a long time. Certainly, in the case of recurrence after a shorter time, it's most often in the prostate bed, although some research where PSMA PET scans were performed before the prostate bed treatment found that in 40% of cases, the results from the PSMA PET scan changed the pattern of salvage radiotherapy dose that would have been delivered without having had the scan first. For patients with recurrence after a long time, you'd probably have to split them into those who were still being monitored at least yearly, and those who weren't, as I might expect that to have a significant impact on extent and location of recurrence.

In the case where substantial spread has occurred, no one is going to go back and investigate how that happened, as it would be very difficult to do and it's of no clinical significance (i.e. it won't change how it's treated).

Nowadays, seminal vesicles are always removed with the prostate even if not thought to be involved in the cancer, but that hasn't always been the case, and might not have been the case in some people having recurrence ≥10 years later today. Actual spread to seminal vesicles (T3b) reduces the likelihood of a prostatectomy being curative, and most surgeons will not operate if this is the suspected staging before the surgery, and radiotherapy is available for the patient.

User
Posted 06 Oct 2023 at 08:22

Thanks Andy, plenty of food for thought as usual. The PSMA PET scan pops up again as a vital tool for locating cancer.

I was asking about micro-mets because in the understandable lack of information about something that is untraceable there's quite a lot of assumptions out there about where they are and what their role is. Best to stick with what we know and can measure for now I guess.

Jules

 
Forum Jump  
<123
©2025 Prostate Cancer UK